BRUKER BIOMEDICAL SYSTEMS ACQUIRES GONOTEC,
A LEADING MARKET PLAYER IN FREEZING POINT OSMOMETRY
Logan, UT, July 15, 2021 – Bruker Biomedical Systems, market leader in global vapor pressure osmometer technology, announces the acquisition of GONOTEC, a leading market player in freezing point osmometer technology.
The purchase of the company unites two osmometry market leaders, providing the industry with a full range of osmometry solutions that meet specific needs enabling physicians to more rapidly and accurately diagnosis disease and determine the proper course of patient treatment.
In addition, Bruker Biomedical Systems will now have a direct market presence in Germany enabling the company to serve customers with its entire portfolio of products and solutions directly.
“The strategic acquisition of GONOTEC expands the company’s global capabilities to deliver innovative products to the in vitro diagnostics, biotech, chemical, environmental, food & beverage, pharmaceutical, and research market segments. With a combined 90+ years of innovation, we aim to become the number one osmometry company in the world,” said Bryce McEuen, Vice President, Biomedical Systems. “In addition, the acquisition increases our capacity and geographic presence to serve laboratories with superior levels of service and customer support.”
For more information about our osmometry solutions, visit Osmometers.com.
About Bruker Biomedical Systems
Bruker Biomedical Systems, is proud to be the World Leader in Aerospray® staining technology and Cytocentrifugation used in hematology, gram, tuberculosis, and cytology staining. In addition, the company is the gold standard in the U.S. and around the world for conducting diagnostic tests to determine cystic fibrosis and provide specialized Erythrocyte Sedimentation Rate (ESR) to assess and analyze blood samples from patients for a variety of hematology disorders and inflammation. Biomedical Systems also offer vapor pressure and freezing point osmometers for clinical, industry, research, and pharmaceutical labs.
Offering reliable solutions in performance and reliability, to more than 100 countries, Biomedical Systems’ mission is to improve patient care by empowering laboratories to do more in less time, with accuracy, to enable rapid and accurate course of treatment for patients.
###